Date Title Description PDF
24 Feb 2021 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
27 Nov 2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia Download
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
05 Nov 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 3 and 4 November Download
03 Nov 2021 On business and financial situation The Company releases the first nine months 2021 financial results presentation Download
03 Nov 2021 On business and financial situation The Company releases the press release related to the first nine months 2021 financial results Download
21 Oct 2021 Liquidity and counterparty agreements Download
21 Oct 2021 On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Download

Pages

Date Title Description PDF
08 Nov 2016 Información sobre resultados ROVI releases the presentation related to the nine-month period ended 30 September 2016 results Download
08 Nov 2016 Información sobre resultados (2) ROVI releases the press release related to the nine-month period ended 30 September 2016 results Download
08 Nov 2016 Otros sobre Gobierno Corporativo The Company informs about the agreement of the Board of Directors with regards to the appointment of the Accounts Auditor Download
04 Oct 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the third quarter of 2016 Download
01 Aug 2016 Acuerdos estratégicos con terceros ROVI announces the marketing agreement of Mysimba in Spain Download

Pages